Clinical Trial Update: Gemcitabine Plus Ascorbate for Sarcoma in Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine plus ascorbate in adults with sarcoma; trial status terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Bone Tumor
• Sarcoma
• Soft Tissue Sarcoma
• Unresectable Soft Tissue Sarcoma

Drugs mentioned

• Ascorbate (ascorbate)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Mohammed Milhem, MBBS | Conditions: Sarcoma, Soft Tissue Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2020-12-10